FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Amgen

Sort
E.g., 2013-05-20
E.g., 2013-05-20
Enter a comma separated list of user names.

HEB, Hemispherx BioPharma, Inc.

** HEB reported that ANMAT (Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica), the agency responsible for the national regulation of drugs, foods and medical technology in Argentina, has approved the sale and distribution of Alferon N Injection(R) (under the brand name "Naturaferon") in Argentina.

Amgen, Inc (NASDAQ:AMGN) is an independent biotechnology medicines company. Amgen discovers, develops, manufactures and markets medicines for grievous illnesses. Amgen, Inc achieved its new 52 week high price of $69.63 where it was opened at $69.10 up 0.43 points or +0.62% by closing at $69.57.

Amgen Showed up and doing - NASDAQ:AMGN

Posted by tom on January 18th, 2012

Amgen, Inc (NASDAQ:AMGN) is an independent biotechnology medicines company. Amgen discovers, develops, manufactures and markets medicines for grievous illnesses. Amgen, Inc achieved its new 52 week high price of $68.47 where it was opened at $67.90 up 0.47 points or +0.70% by closing at $68.07.

Amgen, Inc marks Active Volume - NASDAQ:AMGN

Posted by tom on January 12th, 2012

Amgen, Inc (NASDAQ:AMGN) is an independent biotechnology medicines company. Amgen discovers, develops, manufactures and markets medicines for grievous illnesses. Amgen, Inc achieved its new 52 week high price of $66.45 where it was opened at $65.26 up 0.73 points or +1.11% by closing at $66.40.

Amgen with a Slight Rise - NASDAQ:AMGN

Posted by david on January 11th, 2012

Amgen, Inc (NASDAQ:AMGN) is an independent biotechnology medicines company. Amgen discovers, develops, manufactures and markets medicines for grievous illnesses. Amgen, Inc achieved its new 52 week high price of $65.70 where it was opened at $64.55 up 1.47 points or +2.29% by closing at $65.67.

Amgen, Inc Stocks Closed in Green - NASDAQ:AMGN

Posted by akki on December 23rd, 2011

Amgen, Inc. (NASDAQ:AMGN) is an independent biotechnology medicines company. Amgen discovers, develops, manufactures and markets medicines for grievous illnesses. It focuses on human therapeutics and concentrates on medicines based on advances in cellular and molecular biology. Amgen, Inc.

Pages

ADVERTISE WITH US